Literature DB >> 32602061

Evidence-Based Follow-Up Schedules After Primary Cancer Treatment.

Rachael L Morton1,2, John F Thompson3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32602061     DOI: 10.1245/s10434-020-08768-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.

Authors:  Wei-Yin Lim; Rachael L Morton; Robin M Turner; Marisa C Jenkins; Pascale Guitera; Les Irwig; Angela C Webster; Mbathio Dieng; Robyn P M Saw; Donald Low; Cynthia Low; Katy J L Bell
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

2.  Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.

Authors:  Lucie Rychetnik; Kirsten McCaffery; Rachael L Morton; John F Thompson; Scott W Menzies; Les Irwig
Journal:  J Surg Oncol       Date:  2012-10-22       Impact factor: 3.454

Review 3.  Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature.

Authors:  D A Montgomery; K Krupa; T G Cooke
Journal:  Br J Cancer       Date:  2007-11-13       Impact factor: 7.640

4.  ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB-IIC Patients After 3 Years.

Authors:  Marc Moncrieff; Beverly Underwood; Jennifer Garioch; Martin Heaton; Nakul Patel; Esther Bastiaannet; Josette Hoekstra-Weebers; Harald Hoekstra
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.